Artificial Intelligence

With burnout and financial woes plaguing healthcare, Altera Digital Health bets on advanced AI to ease burdens and restore the human touch at HIMSS26.

As AI reshapes software, Tricentis is taking its Transform conference global, pushing a new paradigm of 'agentic quality engineering.' Here's what it means.

Georgia partners with NTT DATA on a massive IT modernization project, promising enhanced cybersecurity and streamlined services for millions of citizens.

A new partnership uses AI and real-time payments to slash financial risk, unlock capital, and turn energy-hungry industries into powerful grid allies.

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.

Former Novo Nordisk CSO Marcus Schindler joins Cradle, validating AI's role in accelerating drug discovery and reshaping traditional pharmaceutical R&D.

How a strategic tech partnership manages thousands of fans for PBS's top show, revealing the complex logistics behind free, high-demand cultural events.

After a kidney trial setback, CalciMedica's lead drug Auxora shows strong promise for acute pancreatitis, but a tight cash runway looms over its future.

A new partnership turns existing conference rooms into high-quality TV studios, aiming to boost ROI, culture, and the quality of corporate events.

EyeMD EMR rebrands as Optivate, launching a unified, AI-driven platform. This move signals a new chapter for eye care practice management.

Axxess's upcoming conference tackles AI's role in home health, unveils a new leadership certification, and honors an industry titan. Here's what it means.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

Ziff Davis nets a massive windfall by selling its Connectivity division, including Ookla and Speedtest, to Accenture in a deal reshaping network intelligence.

Modaxo's new brand, Aerivo, emerges from an ADB SAFEGATE acquisition, poised to enhance airport efficiency with its cloud-native Flightivity suite.

A new partnership aims to solve the AI industry's energy crisis, bringing high-efficiency liquid cooling to thousands of data centers.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A new report reveals Canadians are overwhelmed by scams, making them vulnerable to AI-driven fraud. Is a national strategy enough to fight back?